Thyssenkrupp Nucera Adjusts 2025/26 Sales and EBIT Forecast

Thyssenkrupp Nucera AG & Co. KGaA has revised its sales and EBIT projections for the 2025/26 fiscal year due to elevated project costs. The adjustments affect both the overall Group outlook and the green hydrogen (gH2) segment specifically. Increased expenses related to optimization measures and a terminated contract for a pilot plant in the U.S. have contributed to this revision.

Originally, the EBIT for the gH2 segment was projected between EUR –80 million and EUR –55 million, but is now anticipated to be between EUR –125 million and EUR –90 million. Sales expectations in the gH2 segment have also been lowered significantly. Conversely, the Chlor-Alkali segment's performance has bolstered its EBIT range slightly.

Group-level sales are now projected between EUR 450 million and EUR 550 million, down from the previous anticipation of EUR 500 million to EUR 600 million.